Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.
Progesterone receptor (PR), a member of the nuclear receptor superfamily, is a key regulator of several processes in reproductive function. We have studied the dynamics of the interaction of PR with a natural target promoter in living cells through the use of fluorescence recovery after photobleaching (FRAP) analysis and also have characterized the dynamics of the interaction of PR with the mouse mammary tumor virus (MMTV) promoter reconstituted into chromatin in vitro. In photobleaching experiments, PR in the presence of the agonist R5020 exhibits rapid exchange with the MMTV promoter in living cells. Two PR antagonists, RU486 and ZK98299, have opposite effects on receptor dynamics in vivo. In the presence of RU486, PR binds to the promoter and is exchanged more slowly than the agonist-activated receptor. In contrast, PR bound to ZK98299 is not localized to the promoter and exhibits higher mobility in the nucleoplasm than the agonist-bound receptor. Significantly, PR bound to R5020 or RU486 can recruit the SWI/SNF chromatin remodeling complex to the promoter, but PR activated with ZK98299 cannot. Furthermore, we found ligand-specific active displacement of PR from the MMTV promoter during chromatin remodeling in vitro and conclude that the interaction of PR with chromatin is highly dynamic both in vivo and in vitro. We propose that factor displacement during chromatin remodeling is an important component of receptor mobility and that ligand-specific interactions with remodeling complexes can strongly influence receptor nuclear dynamics and rates of exchange with chromatin in living cells.
Rayasam
Geetha V
GV
Laboratory of Receptor Biology and Gene Expression, Building 41, B602, National Cancer Institute, National Institutes of Health, 41 Library Dr., Bethesda, MD 20892-5055, USA.
Elbi
Cem
C
Walker
Dawn A
DA
Wolford
Ronald
R
Fletcher
Terace M
TM
Edwards
Dean P
DP
Hager
Gordon L
GL
D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D002843:Chromatin / Q000378:metabolism*; D042002:Chromatin Assembly and Disassembly / Q000235:genetics / Q000502:physiology*; D004265:DNA Helicases; D036681:Fluorescence Recovery After Photobleaching; D006067:Gonanes / Q000494:pharmacology; D049452:Green Fluorescent Proteins / Q000032:analysis / Q000235:genetics; D006801:Humans; D008024:Ligands; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics; D015735:Mifepristone / Q000494:pharmacology; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D011397:Promegestone / Q000494:pharmacology; D011401:Promoter Regions, Genetic / Q000235:genetics; D011980:Receptors, Progesterone / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*
D002843:Chromatin; D006067:Gonanes; D008024:Ligands; D009687:Nuclear Proteins; D011980:Receptors, Progesterone; D014157:Transcription Factors; C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D015735:Mifepristone; D011397:Promegestone; C084108:SMARCA4 protein, human; C513194:Smarca4 protein, mouse; D004265:DNA Helicases; C053238:onapristone
Science. 1992 Dec 4;258(5088):1598-604
1360703
Science. 2001 Feb 2;291(5505):843-7
11225636
Endocrinology. 1998 Apr;139(4):1905-19
9528977
Anal Biochem. 1976 May 7;72:248-54
942051
Mol Cell Biol. 2000 Sep;20(17):6466-75
10938123
Mol Cell. 2003 Mar;11(3):695-707
12667452
Mol Cell Biol. 2002 May;22(10):3255-63
11971959
Ann N Y Acad Sci. 2004 Jun;1024:213-20
15265783
Nucleic Acids Res. 1998 Aug 15;26(16):3657-66
9685480
Science. 2002 Jun 21;296(5576):2232-5
12077419
J Biol Chem. 2003 Aug 15;278(33):30605-13
12775722
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4421-5
8506282
Biochemistry. 1992 Nov 3;31(43):10491-501
1420166
Cell. 2002 Feb 22;108(4):465-74
11909518
Mol Endocrinol. 1999 Mar;13(3):366-75
10076994
J Biol Chem. 1996 Jan 5;271(1):153-9
8550551
Genes Dev. 1995 Aug 1;9(15):1933-47
7649476
Nucleic Acids Res. 1991 Mar 25;19(6):1227-34
2030942
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2876-81
14978266
Prog Nucleic Acid Res Mol Biol. 2001;66:279-305
11051767
Oncogene. 2001 May 28;20(24):3047-54
11420720
Mol Cell Biol. 1998 Jun;18(6):3633-44
9584204
Mol Cell. 2004 Apr 23;14(2):163-74
15099516
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7940-4
12048256
Exp Biol Med (Maywood). 2002 Dec;227(11):969-80
12486206
J Biol Chem. 2003 Oct 10;278(41):39261-4
12893816
Mol Cell Biol. 2004 Apr;24(7):2682-97
15024059
Cell. 2003 Dec 12;115(6):751-63
14675539
EMBO Rep. 2002 Dec;3(12):1188-94
12446572
Cell. 2003 Aug 8;114(3):277-80
12914692
J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):449-58
7626494
Gene. 1997 Mar 25;188(1):95-100
9099865
Biochim Biophys Acta. 2004 Mar 15;1677(1-3):46-51
15020044
Genes Dev. 1995 Jun 1;9(11):1366-76
7797076
EMBO J. 1993 Nov;12(11):4279-90
8223438
Mol Cell Biol. 2000 May;20(9):3102-15
10757795
Methods. 1999 Nov;19(3):386-93
10579933
Science. 2000 Feb 18;287(5456):1262-5
10678832
Mol Cell Biol. 1999 Jun;19(6):3931-9
10330133
J Biol Chem. 2004 Apr 16;279(16):16677-86
14701856
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11333-7
7972059
Mol Cell Biol. 2001 Jul;21(13):4404-12
11390668
Mol Cell Biol. 2000 Apr;20(8):2839-51
10733587
Mol Cell Biol. 1998 Aug;18(8):4471-87
9671457
Nature. 1998 May 7;393(6680):88-91
9590696
EMBO J. 1988 Oct;7(10):3073-9
2846275
Mol Cell Biol. 2004 Jun;24(11):4651-63
15143161